Rx only · Capsule · Oral

Lisdexamfetamine Dimesylate

Brands: Vyvanse · Lisdexamfetamine Dimesylate

15 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US105 NDCs
15 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCN06BA12

RxCUI (US)700810

US makers15 labelers

Packages116

DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 97 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.471

Latest avg · Jul 22, 2026

-12%

Since Dec 17, 2025

Active US suppliers

22%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.8M

Rx · 2026 Q1

52.4M

Units dispensed

-0%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it15 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Bryant Ranch Prepack	repackager	19	SUPPLYING
Lannett Company, Inc.	unknown	7	SUPPLYING
Teva Pharmaceuticals USA, Inc.	unknown	7	SUPPLYING
Hikma Pharmaceuticals USA Inc.	unknown	7	SUPPLYING
Sandoz Inc	unknown	7	SUPPLYING
SpecGx LLC	unknown	7	SUPPLYING
Takeda Pharmaceuticals America, Inc.	unknown	7	SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.	unknown	7	SUPPLYING
Granules Pharmaceuticals Inc	unknown	7	SUPPLYING
Camber Pharmaceuticals, Inc.	unknown	7	SUPPLYING
Rhodes Pharmaceuticals LLC	unknown	7	SUPPLYING
Alvogen Inc.	unknown	7	SUPPLYING
Apotex Corp.	unknown	7	SUPPLYING
Elite Laboratories, Inc	unknown	7	SUPPLYING
American Health Packaging	unknown	6	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Oct 28, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Bru…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — U.S Nationwide.
Oct 28, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Bru…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — U.S Nationwide.
Oct 28, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Bru…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — U.S Nationwide.
Oct 28, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Bru…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — U.S Nationwide.
Oct 28, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Bru…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — U.S Nationwide.
Oct 28, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Bru…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — U.S Nationwide.
Oct 28, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Bru…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — U.S Nationwide.
Aug 11, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philade…
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg. — Recalling firm: Lannett Company Inc. — Nationwide within the USA
Jun 16, 2025
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Br…
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH). — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
Oct 25, 2024
RECALLRecall (Class II): Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadel…
Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity. — Recalling firm: Lannett Company Inc. — Nationwide in the USA
Nov 1, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Apotex Corp.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Apotex Corp.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Tablet, Chewable (Takeda Pharmaceuticals USA Inc.)
Lisdexamfetamine Dimesylate Tablet, Chewable — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Teva Pharmaceuticals USA, Inc.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Lannett Company, Inc.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Lannett Company, Inc.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (SpecGx LLC)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by SpecGx LLC. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Alvogen)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Alvogen. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Takeda Pharmaceuticals USA Inc.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Sun Pharmaceutical Industries, Inc.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Sun Pharmaceutical Industries, Inc.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Hikma Pharmaceuticals USA, Inc.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Rhodes Pharmaceuticals L.P.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Rhodes Pharmaceuticals L.P.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Capsule (Elite Laboratories, Inc.)
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Elite Laboratories, Inc.. Therapeutic category: Psychiatry.
Jul 14, 2023
SHORTAGEDrug shortage: Lisdexamfetamine Dimesylate Tablet, Chewable (Sun Pharmaceutical Industries, Inc.)
Lisdexamfetamine Dimesylate Tablet, Chewable — reported in shortage by Sun Pharmaceutical Industries, Inc.. Therapeutic category: Psychiatry.
Sep 2, 2016
RECALLRecall (Class III): Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexi…
Presence of Foreign Tablets/Capsules — Recalling firm: Shire — Nationwide